Canada - April 6 2022
On March 3, 2022, the Patented Medicine Prices Review Board (the “PMPRB” or the “Board”) released its 2022-23 Departmental Plan [PDF] outlining its…
Eric Saragosa
Canada - February 28 2022
Since the August 2019 amendments to the Patented Medicines Regulations (the “Amendments”), three cases challenging the Patented Medicine Prices…
Eric Saragosa
Canada - February 21 2022
In a much-anticipated decision, which will likely have a substantial impact on the pharmaceutical industry in Canada, the Quebec Court of Appeal…
Mathieu Gagné
Canada - February 20 2022
Dans une décision très attendue qui aura probablement un impact important sur l’industrie pharmaceutique au Canada, la Cour d’appel du Québec a…
Mathieu Gagné
Canada - February 14 2022
In Canada, coverage for prescription drugs currently exists through an array of public and private drug plans. To ensure accessibility of drugs to…
Lina Bensaidane
